SCHEDULE 13G/A: Greenleaf Trust Amends Stryker Corp Stake, Reports 4.7% Beneficial Ownership

Greenleaf Trust has filed an Amendment No. 18 to its Schedule 13G, disclosing a 4.7% beneficial ownership stake in Stryker Corp as of December 31, 2024.

Summary

• Greenleaf Trust, a bank based in Michigan, has filed an Amendment No. 18 to its Schedule 13G regarding its beneficial ownership in Stryker Corp.
• As of December 31, 2024, Greenleaf Trust beneficially owned an aggregate of 17,981,458 shares of Stryker Corp's Common Stock, representing 4.7% of the class.
• The ownership breakdown includes 140,441 shares with sole voting power and 17,841,017 shares with shared voting power.
• Regarding dispositive power, Greenleaf Trust holds 101,325 shares with sole dispositive power and 17,880,133 shares with shared dispositive power.
• Greenleaf Trust certifies that these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Stryker Corp.
• The securities are held in a fiduciary capacity on behalf of various trust and investment management customers.

Sentiment

Score: 5

Explanation: The filing is a routine beneficial ownership disclosure (Schedule 13G Amendment) and does not contain information that would typically indicate positive or negative sentiment regarding the issuer's performance or outlook. It simply updates the reported stake of an existing institutional investor.

Positives

• The continued significant beneficial ownership by Greenleaf Trust, a bank acting in a fiduciary capacity, indicates ongoing institutional confidence in Stryker Corp as an investment for its clients.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Stryker Corp's future performance or outlook.

Management Comments

• Greenleaf Trust's President, Michael F. Odar, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing reflects the ongoing investment activities of institutional asset managers like Greenleaf Trust within the healthcare and medical technology sector, specifically in a major player like Stryker Corp. It highlights how large financial institutions manage significant stakes on behalf of their clients, contributing to the broader ownership structure of publicly traded companies.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake in Stryker Corp, confirming Greenleaf Trust's continued investment on behalf of its clients.

Key Dates

Keywords

Stryker Corp, Greenleaf Trust, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Medical Technology, Healthcare, SEC Filing